Nano Dimension Announces Formal Offer to Acquire Stratasys
All-Cash Offer Represents a 36% Premium to Unaffected Closing Stock Price as of March 1, 2023 Combination Would Create
Globe Newswire10-03-2023, 04:43
Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma 2-10-2024, 19:00